Purpose: Liver X receptors (LXRs) are key transcriptional regulators of lipid and carbohydrate metabolism. Moreover, LXR activation with synthetic agonists was shown to reduce left ventricular (LV) hypertrophy and prevent cardiac dysfunction, albeit at the expense of eliciting adverse systemic side effects such as hypertriglyceridemia and liver steatosis. To circumvent these confounding effects, we generated a murine model whereby LXR signaling is selectively increased in the heart. Thus, the aim of this study was to determine whether cardiac-specific LXR activation reduces pathological cardiac hypertrophy, and furthermore, explore the relevance of LXRs in regulating glucose and lipid metabolism in the heart. Methods: Murine LXRα was cloned behind the αMHC promoter to create transgenic (TG) mice and transgene-negative littermates (CON). TG and CON mice were subjected to transverse aortic constriction (TAC), or sham surgery, for 5 weeks to induce LV hypertrophy. In vivo cardiac function was assessed with echocardiography. Results: In TG mice, basal myocardial LXRα protein levels were increased 10-fold. TAC significantly increased LV weight in both CON and TG, however, LV weight increase was 24% less in TG (P<0.001). CON mice exhibited a greater decline in fractional shortening after TAC (-11% vs -6%, P<0.001). Following TAC, typical changes in fetal gene expression were observed in CON, but to a lesser extent in TG mice. Further investigation into the molecular basis of LXR-mediated cardioprotection with microarray analysis revealed alterations in both glucose and lipid homeostasis. TAC suppressed fatty acid oxidation genes in both CON and TG, but genes involving glucose metabolism were increased in TG. In particular, Glut1 and Glut4 expression were significantly induced in TG hearts (P<0.05 vs CON). To this end, myocardial glucose uptake was assessed using 18F-FDG measured by PET imaging. Basal cardiac FDG-glucose uptake was enhanced in TG mice (P<0.05 vs CON). Following TAC, FDG-glucose uptake increased in both CON and TG, but to a larger extent in TG (P<0.05). This adaptation coincided with a more lean phenotype as intracardiac lipid levels were significantly lower in TG mice (P<0.05 vs CON). Conclusion: Our gain-of-function studies indicate that constitutive LXR activation in the heart is beneficial in reducing cardiac pressure overload-induced LV hypertrophy and dysfunction. Furthermore, LXR-mediated increases in glucose utilization constitute these cardioprotective effects, and we therefore postulate that LXR activation could be a potential therapeutic target. Purpose: Integrity of vascular smooth muscle cell (SMC) function plays an important role in the development and progression of atherosclerosis. Increasing evidence has given credit to elevated plasma free fatty acids as crucial risk factor for atherosclerotic disease in obese or diabetic patients. However, little is known about the molecular mechanism by which disturbance of fatty acid metabolism in VSMC results in atherosclerosis. In this study, we focused on two fatty acid catalytic enzymes, stearoyl-CoA desaturase 1 (SCD1), that catalyzes the synthesis of monounsaturated fatty acids (MUFA) from saturated fatty acids (SFA), and elongase of long chain fatty acids 6 (Elovl6), that catalyzes the elongation of long-chain SFA and MUFA. Methods and results: We first examined SCD1 and Elovl6 expressions in neointimal hyperplasia by immunohistochemistry. Both SCD1 and Elovl6 were colocalized with smooth muscle alpha-actin-positive cells in medial layer of normal vessels while they were dramatically increased in 14-day balloon-injured rat aortas or intimal thickening area of human coronary artery. Furthermore, SCD1 and Elovl6 mRNA expressions in cultured human aortic SMC (HASMC) were significantly increased by transforming growth factor-beta (TGF-b; 15.2-fold) or platelet-derived growth factor-BB (PDGF-BB; 2.4-fold) which is negative regulator of SMC differentiation. We next examined whether SCD1 or Elovl6 expressions affect cell proliferation in VSMC. Knockdown of SCD1 or Elovl6 expressions in HASMC significantly suppressed DNA synthesis measured by [3H]-thymidine incorporation (63% and 16%, respectively, relative to control, p<0.01). These effects were blunted by adenovirus-mediated overexpression. Furthermore, SCD1 or Elovl6 knockdown markedly induced p21 and p53 expressions, phospholyration of AMP-activated protein kinase (p-AMPK) and suppressed mTOR expression levels, which lead to inhibit cell proliferation. Of importance, analysis of FFA composition in VSMC showed that both SCD1 and Elovl6 knockdown markedly increased the proportion of palmitic acid, while decreased that of MUFAs such as palmitoleic acid or oleic acid. In accordance with these results, palmitic acid substantially suppressed DNA synthesis and induced p21 or p-AMPK expressions.
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Fatty acid catalytic enzymes in vascular smooth muscle cells play a crucial role in the pathogenesis of atherosclerosis
Purpose: Integrity of vascular smooth muscle cell (SMC) function plays an important role in the development and progression of atherosclerosis. Increasing evidence has given credit to elevated plasma free fatty acids as crucial risk factor for atherosclerotic disease in obese or diabetic patients. However, little is known about the molecular mechanism by which disturbance of fatty acid metabolism in VSMC results in atherosclerosis. In this study, we focused on two fatty acid catalytic enzymes, stearoyl-CoA desaturase 1 (SCD1), that catalyzes the synthesis of monounsaturated fatty acids (MUFA) from saturated fatty acids (SFA), and elongase of long chain fatty acids 6 (Elovl6), that catalyzes the elongation of long-chain SFA and MUFA. Methods and results: We first examined SCD1 and Elovl6 expressions in neointimal hyperplasia by immunohistochemistry. Both SCD1 and Elovl6 were colocalized with smooth muscle alpha-actin-positive cells in medial layer of normal vessels while they were dramatically increased in 14-day balloon-injured rat aortas or intimal thickening area of human coronary artery. Furthermore, SCD1 and Elovl6 mRNA expressions in cultured human aortic SMC (HASMC) were significantly increased by transforming growth factor-beta (TGF-b; 15.2-fold) or platelet-derived growth factor-BB (PDGF-BB; 2.4-fold) which is negative regulator of SMC differentiation. We next examined whether SCD1 or Elovl6 expressions affect cell proliferation in VSMC. Knockdown of SCD1 or Elovl6 expressions in HASMC significantly suppressed DNA synthesis measured by [3H]-thymidine incorporation (63% and 16%, respectively, relative to control, p<0.01). These effects were blunted by adenovirus-mediated overexpression. Furthermore, SCD1 or Elovl6 knockdown markedly induced p21 and p53 expressions, phospholyration of AMP-activated protein kinase (p-AMPK) and suppressed mTOR expression levels, which lead to inhibit cell proliferation. Of importance, analysis of FFA composition in VSMC showed that both SCD1 and Elovl6 knockdown markedly increased the proportion of palmitic acid, while decreased that of MUFAs such as palmitoleic acid or oleic acid. In accordance with these results, palmitic acid substantially suppressed DNA synthesis and induced p21 or p-AMPK expressions.
Conclusions:
Collectively, our results suggest that perturbation of fatty acid desaturation or elongation in VSMC causes the shift of fatty acid composition and the inhibition of cell proliferation. Therefore, fatty acid metabolism and composition is crucial for SMC proliferation and progression of atherosclerosis.
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MicroRNA-100 regulates a cluster of adipocytokine expression: A human biopsy study in subcutaneous and visceral adipose tissue Purpose: MicroRNAs (miRNA), single-stranded non-protein coding gene products, regulate gene expression through post-transcriptional inhibition, and known to be involved in essential biological processes including obesity and insulin resistance. This study was conducted to elucidate the role of miR100 expression in human adiposity and insulin resistance. Methods: Pair samples were obtained from subcutaneous (SAT) and visceral adipose tissue (VAT) during elective operation in 71 men and 42 women. Mature miRNA levels were determined by qRT-PCR and normalized to levels of U6 small nuclear ribonucleoprotein. Subcutaneous (SFA) and visceral fat area (VFA) was determined by abdominal multidetector CT scanning. Adipocyte sizing was determined by the osmium-fixed method on a Coulter counter. Results: Study 1 (clinical study): In men and women, SFA was larger than VFA, and the mean size of adipocytes was greater in SAT than in VAT. Level of log(miR100) was significantly decreased in VAT in men (p=0.025), but comparable between SAT and VAT in women. Level of log(miR100) in VAT was positively correlated with HOMA-IR, and tended to be positively correlated with expression level of macrophage marker, CD68. Level of log(miR100) in SAT was positively correlated with expression level of IL1β, NLRP3 and TLR4 in men but not in women. Study 2 (in vitro study): When stimulated with lipopolysaccharide (LPS, 1-10ng/mL), expression of miR100 was not changed in mouse macrophage-like Raw264.7 cells, but enhanced in adipocyte-like 3T3-L1 cells. A member of the NOX family of NADPH oxidases NOX4, which has a possible MiR100 target at 3'-UTR, was up-regulated in 3T3-L1 cells by LPS, but not changed in Raw264.7 cells. NOX2, another type of NADPH oxidase, was not detected in 3T3L1 cells but was in Raw264.7 cells. Conclusion: Adipose tissue miR100 is derived mostly from adipocytes and may play a direct or indirect role in regulating expressions of adipocyte inflammatory cytokines, adipocyte-specific NADPH oxidase, and insulin sensitivity in human.
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Effects of granulocyte-colony stimulating factor on obesity and energy metabolism in male Otsuka-Long-Evans-Tokushima fatty rats
